Skip to content
TRYGENESIS
Medication

NAD+

Compounded

What it is

Nicotinamide adenine dinucleotide is a coenzyme involved in cellular energy metabolism and DNA repair. Levels decline with age. It is offered by subcutaneous injection or intravenous infusion in compounded form.

How it is used

Administered by subcutaneous injection at home, or by infusion in a clinical setting. Protocols vary and are set by the prescriber; there is no standardised regimen.

What a provider evaluates first

  • General health status and relevant baseline laboratory work
  • Tolerance, since infusion is commonly associated with flushing and discomfort at speed
  • Whether an approved therapy addresses the underlying concern

Considerations and monitoring

  • Compounded and not FDA-approved for this use
  • Clinical evidence for longevity outcomes in humans is limited
  • Infusion-related discomfort is common and rate-dependent

Questions about nad+

What is NAD+ therapy?

NAD+ is a coenzyme central to cellular energy metabolism and DNA repair, and its levels decline with age. It is offered as a compounded preparation by subcutaneous injection or intravenous infusion. It is not FDA-approved for this use, clinical evidence for longevity outcomes in humans is limited, and protocols are not standardised. Infusion is commonly associated with flushing and discomfort, which is rate-dependent.

Part of Longevity & NAD+.